Skip to main content
. 2016 Aug 31;12(3):216–226. doi: 10.1016/j.ajps.2016.08.007

Fig. 3.

Fig. 3

Release profiles (mean ± SD, n ≥ 3) of duloxetine pellets coated with Aqoat® AS-LF (A) affected by weight gain without NH3; (B) affected by the enteric suspension with or without NH3; (C) affected by weight gain with NH3, and Cymbalta® after 2 h 0.1 mol/l HCL and subsequently at pH 6.8.